UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 12b-25

NOTIFICATION OF LATE FILING
(Check one): ☐Form 10-K   ☒Form 20-F   ☐Form 11-K ☐Form 10-Q   ☐ Form N-SAR   ☐Form N-CSR
 

For Period Ended:    December 31, 2018

☐Transition Report on Form 10-K
☐Transition Report on Form 20-F
☐Transition Report on Form 11-K
☐Transition Report on Form 10-Q
☐Transition Report on Form N-SAR
 
For the Transition Period Ended:
 
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I -- REGISTRANT INFORMATION
 
Full Name of Registrant
 
TRINITY BIOTECH PLC 
                                                                                                                                      
Former Name if Applicable

                                 
Address of Principal Executive Office (Street and Number)
 
IDA BUSINESS PARK, BRAY, COUNTY WICKLOW, IRELAND, A98 H5C8      
                                                                       
City, State and Zip Code
  
 
 
PART II -- RULES 12b-25(b) AND (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
 
 
 ☒
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
 
 
 ☒
 
(b)
 
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
 
 
 
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
 
 
 
PART III -- NARRATIVE
 
The Registrant is unable to file its Annual Report on Form 20-F for the year ended December 31, 2018 within the prescribed time period because of unanticipated delays in the completion of its financial statements and related portions of the Form 20-F due to resource constraints, which delays could not be eliminated by the Registrant without unreasonable effort and expense.  The Company expects to file the Form 20-F within the fifteen-calendar day extension provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended.
PART IV -- OTHER INFORMATION
 
(1) Name and telephone number of person to contact in regard to this notification
 
Kevin Tansley
(  +353 )
   12769800         
 (Name)
  (Area Code)
  (Telephone Number)
 
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
 
Yes x No☐
 
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? 
Yes ☐   No ☒

The Company does not expect any changes to the financial results it previously reported in its press release on Form 6-K filed March 8, 2019.
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
 
TRINITY BIOTECH PLC 
 (Name of Registrant as Specified in Charter)
 
 
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated:  May 1, 2019
By:  
/s/  KEVIN TANSLEY                                          
 
Kevin Tansley 
 
Chief Financial Officer